Silo Pharma Inc (SILO) — Cash Flow-to-Debt Ratio
Silo Pharma Inc (SILO) has a Cash Flow-to-Debt Ratio of -0.62x as of March 2026, meaning its operating cash flow of $-822.62K could theoretically repay -1% of its total liabilities ($1.34 Million) in one year. See SILO cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Silo Pharma Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Silo Pharma Inc across 15 annual periods. Also explore SILO year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Silo Pharma Inc (2011–2025)
Year-by-year debt coverage analysis for Silo Pharma Inc. For market capitalisation and broader financial context, see SILO stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.59x | $-4.66 Million | $1.30 Million | ▼ -122.4% |
| 2024 | -1.61x | $-3.83 Million | $2.38 Million | ▲ +21.5% |
| 2023 | -2.05x | $-3.22 Million | $1.57 Million | ▲ +23.5% |
| 2022 | -2.69x | $-3.50 Million | $1.30 Million | ▼ -68.4% |
| 2021 | -1.60x | $-2.28 Million | $1.43 Million | ▲ +79.9% |
| 2020 | -7.93x | $-1.16 Million | $145.97K | ▼ -415.6% |
| 2019 | -1.54x | $-794.32K | $516.74K | ▼ -352.6% |
| 2018 | 0.61x | $272.64K | $447.98K | ▲ +193.7% |
| 2017 | -0.65x | $-284.62K | $438.34K | ▼ -104.9% |
| 2016 | -0.32x | $-143.56K | $453.10K | ▲ +84.7% |
| 2015 | -2.07x | $-1.02 Million | $490.76K | ▲ +21.5% |
| 2014 | -2.64x | $-1.06 Million | $402.56K | ▼ -508.8% |
| 2013 | -0.43x | $-181.61K | $418.72K | ▲ +16.2% |
| 2012 | -0.52x | $-21.47K | $41.47K | ▲ +96.1% |
| 2011 | -13.23x | $-46.30K | $3.50K | — |